Kinnate Biopharma Inc. Profile Avatar - Palmy Investing

Kinnate Biopharma Inc.

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma…

Biotechnology
US, San Francisco [HQ]

Investor Relations

Could not find a transcript